Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

(603392)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/13/2021 10/14/2021 10/15/2021 10/18/2021 10/19/2021 Date
226.88 223.32 242.55 235.4 235.95 Last
1006117 1033793 2577771 2372140 1302026 Volume
+0.48% -1.57% +8.61% -2.95% +0.23% Change
Estimated financial data (e)
Sales 2021 4 057 M 636 M 636 M
Net income 2021 1 239 M 194 M 194 M
Net Debt 2021 - - -
P/E ratio 2021 94,3x
Yield 2021 0,31%
Sales 2022 5 307 M 832 M 832 M
Net income 2022 1 643 M 257 M 257 M
Net Debt 2022 - - -
P/E ratio 2022 71,3x
Yield 2022 0,42%
Capitalization 143 B 22 441 M 22 442 M
Capi. / Sales 2021 35,3x
Capi. / Sales 2022 27,0x
Nbr of Employees 2 582
Free-Float 10,9%
More Financials
Company
Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Company is also engaged in the sales of agent products. The in-vitro diagnostics include: enzyme-linked immunosorbent assay (ELISA) reagents, chemiluminescence... 
More about the company
Ratings of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
09/24BEIJING WANTAI BIOLOGICAL PHARMACY : to Recruit 40,000 Participants For Nasal Spray COVID-..
MT
09/20BEIJING WANTAI BIOLOGICAL PHARMACY E : 603392) added to S&P Global BMI Index
CI
08/17Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
04/21Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
03/25Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
03/21BEIJING WANTAI BIOLOGICAL PHARMACY E : 603392) added to FTSE All-World Index
CI
03/10MARKET CHATTER : Nongfu Spring Founder Becomes Asia's Richest Person
MT
03/02JACK MA : Jack Ma loses title as China's richest man after coming under Beijing's scrutiny
RE
2020BEIJING WANTAI BIOLOGICAL PHARMACY E : 603392) added to Shanghai Stock Exchange 180 Value ..
CI
2020BEIJING WANTAI BIOLOGICAL PHARMACY E : 603392) added to SSE 180 Index
CI
2020BEIJING WANTAI BIOLOGICAL PHARMACY E : 603392) added to Shanghai Stock Exchange Health Car..
CI
2020Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
2020Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
2020Xiamen Innodx Biotech Co., Ltd. announced that it has received CNY 150 million in fundi..
CI
2020Xiamen Innovax Biotech CO., LTD. announced that it expects to receive CNY 150 million i..
CI
More news
News in other languages on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
09/24Beijing Wantai va recruter 40 000 participants pour l'essai du vaccin COVID-19 en spray..
More news
Chart BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Duration : Period :
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 235,95 CNY
Average target price 339,11 CNY
Spread / Average Target 43,7%
EPS Revisions
Managers and Directors
Zi Xin Qiu General Manager & Director
Yi Yong Zhao Chief Financial Officer
Qing Chao Xing Chairman-Supervisory Board
Shan Shan Zhong Chairman
Yi Min Li Director & Chief Engineer
Sector and Competitors